CNBC Pro Talks: A top fund manager proves you can make massive returns while investing ethically

CNBC Pro Talks: A top fund manager proves you can make massive returns while investing ethically


Want to devote sustainably without sacrificing returns? Sign up for CNBC’s Tanvir Gill as she discusses ethical investing with top rated-executing fund supervisor Philip Ripman.

Ripman’s fund, Storebrand World wide Methods, avoids providers that make more than 5% of their revenues from fossil fuels, tobacco, alcohol, war and other vice-connected things to do. It ranks major for 10-12 months annualized returns (15%) on Morningstar’s list of world-wide mega-cap equity funds.

The portfolio manager at Storebrand Asset Management will discuss his major holdings which incorporate largely massive-cap organizations, ranging from tech giants to health care. They contain Apple, Microsoft, Alphabet, chip giants Nvidia and TSMC, as well as UnitedHealth Group.

Renewable vitality is also a sizzling subject for Ripman, who will focus on concerns such as the impact of geopolitical tensions, electric motor vehicles, battery shares and photo voltaic businesses to look at.

Ripman is centered in Oslo, Norway and has been the fund manager of Storebrand Worldwide Solutions since 2015.

Sign up for CNBC Pro Talks on Wednesday, May 17 at 6:30 a.m. BST / 1:30 p.m. SGT / 1:30 a.m. ET.

Post your queries listed here.



Source

The chart that has Michael Burry worried about the stock market
World

The chart that has Michael Burry worried about the stock market

Michael Burry is warning that a shift in household wealth could leave the stock market vulnerable to a long and significant downturn. “The Big Short” investor pointed to a graphic produced by Wells Fargo showing that U.S. households now hold a larger share of their net worth in equities than in real estate — a […]

Read More
This biotech name is evolving into a major obesity play. How to trade it with options
World

This biotech name is evolving into a major obesity play. How to trade it with options

Amgen is entering a pivotal period the as it moves beyond its Enbrel franchise and repositions around obesity, rare disease and next-generation oncology. While Enbrel has entered a period of decline due to Medicare pricing reform, management has demonstrated credible execution in replacing that cash flow with a higher-quality pipeline. Early success from the Imdelltra […]

Read More
Three holds and a cut? Europe’s central banks are about to make their final calls of 2025
World

Three holds and a cut? Europe’s central banks are about to make their final calls of 2025

A projected illumination marking the 75th anniversary of the Schuman Declaration, on the Grossmarkthalle building at the European Central Bank headquarters in Frankfurt, Germany, on May 9, 2025. Alex Kraus/Bloomberg via Getty Images Investors are gearing up for the last interest-rate decisions of 2025, with four of Europe’s central banks announcing their monetary policies and […]

Read More